Literature DB >> 4101615

Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy.

O K Mjolnerod, S A Dommerud, K Rasmussen, S T Gjeruldsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4101615     DOI: 10.1016/s0140-6736(71)92681-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  D-penicillamine in dermatology: influence on enzymatic activities of human skin in vitro.

Authors:  W Raab; B Gmeiner
Journal:  Arch Dermatol Res       Date:  1975-11-14       Impact factor: 3.017

2.  Wilson's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

3.  Treatment of rheumatic diseases.

Authors:  M A Byron
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-24

4.  Penicillamine therapy and teratogenesis.

Authors:  R Corcoran; W J Castles
Journal:  Br Med J       Date:  1977-03-26

Review 5.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 6.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

7.  D-penicillamine in pregnancy--to ban or not to ban?

Authors:  W Endres
Journal:  Klin Wochenschr       Date:  1981-06-01

Review 8.  Practical recommendations and new therapies for Wilson's disease.

Authors:  G J Brewer
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 9.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

Review 10.  Liver disease in pregnancy.

Authors:  Noel M Lee; Carla W Brady
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.